1. THE NEED

A Persistent Clinical Challenge in Appetite Regulation

Overweight and obesity management relies on a multimodal approach combining behavioral, pharmacological, and surgical strategies.

However, some individuals experience:

  • altered perception of satiety signals
  • difficulty regulating food intake
  • challenges maintaining weight loss over time

This reflects a complex interaction of:

→ physiological

→ behavioral

→ environmental factors

There remains a need for:

  • non-invasive, body-respecting approaches
  • solutions aligned with physiological mechanisms
  • tools that can be integrated within existing care pathways

GASTER control® was developed to address this gap.

2. OUR TECHNOLOGY

Extra-Parietal Balloon (BEP™): External Mechanical Modulation

GASTER control® is based on a biomechanical principle:

controlled external abdominal compression applied to the epigastric region.

At the core of the system lies the Extra-Parietal Balloon (BEP™) —

an anatomically optimized inflatable structure designed to apply adjustable and reproducible pressure.

This approach aims to:

  • influence the perception of gastric volume
  • facilitate earlier recognition of satiety during meals
  • support the regulation of food intake
  • contribute to progressive modulation of eating behaviors

Key Characteristics

  • Non-invasive: no internal device, no surgery, no pharmacological action
  • Adjustable and user-controlled
  • Designed for real-life use during meals
  • Based on biomechanical and physiological principles


Proprietary biomechanical design (patent pending)

3. MECHANISM OF ACTION

A Mechanical Approach to Satiety Perception

Satiety is driven by multiple signals:

  • mechanical (gastric distension)
  • neuro-hormonal

In some individuals, the perception of these signals may be altered.

GASTER control® acts on the mechanical component by:

  • applying targeted epigastric compression
  • modifying the conditions of signal perception
  • supporting earlier integration of satiety cues

This approach does not create satiety,

but modulates the conditions in which it is perceived.

4. USE IN DAILY LIFE

Integration Within the Meal Process

The device can be used across different phases of eating:

  • Pre-meal: preparation of mechanical conditions for signal perception
  • During meals: reinforcement of distension-related signals
  • Post-meal: maintenance of satiety perception

This dynamic use allows integration into real-life eating behaviors.

5. CLINICAL POSITIONING

A Complementary Tool Within Care Pathways

GASTER control® is not a standalone treatment for overweight or obesity.

It is designed as a complementary tool, integrated into structured medical care.

Potential areas of use include:

  • Pre-operative support in bariatric pathways
  • Post-operative management of weight regain
  • Support during or after GLP-1–based treatments
  • Selected first-line situations in patients requiring non-invasive approaches

Clinical Role

  • Support regulation of food intake
  • Assist in portion control
  • Contribute to stabilization phases
  • Provide a non-pharmacological support option

6. CLINICAL INSIGHTS

Exploratory Data in Real-Life Conditions

Preliminary observational data suggest:

  • reduction in meal volume
  • earlier perception of satiety
  • improvement in eating behaviors
  • progressive weight reduction in most users
  • good tolerance and acceptability

These findings are:

  • exploratory
  • consistent with the proposed mechanism
  • currently under further clinical evaluation

7. SAFETY & DESIGN

Engineered for Clinical Use

GASTER control® is developed with a focus on:

  • controlled and adjustable compression
  • anatomical targeting
  • patient comfort and usability
  • reproducibility across body types

The system is:

  • non-invasive
  • reversible
  • compatible with routine clinical use

8. SCIENTIFIC DEVELOPMENT

A Structured Clinical Development Pathway

GASTER control® is currently undergoing:

  • observational clinical evaluation
  • real-world usability studies
  • preparation for controlled trials

A multicentric study is in progress to further define:

  • clinical efficacy
  • optimal patient selection
  • positioning within care pathways


9. MISSION

Advancing Non-Invasive Approaches to Appetite Regulation

GASTER control® aims to:

  • support patients in better understanding their satiety signals
  • provide healthcare professionals with practical, non-invasive tools
  • contribute to the evolution of obesity management strategies

FINAL STATEMENT

A non-invasive biomechanical approach supporting the perception of satiety signals

Grounded in physiology, designed for integration into clinical care pathways, and undergoing continuous scientific evaluation.

Contact form